首页|Wnt/β-catenin信号通路与EMT途径相互作用介导肾癌舒尼替尼耐药的研究

Wnt/β-catenin信号通路与EMT途径相互作用介导肾癌舒尼替尼耐药的研究

扫码查看
目的 研究Wnt/β-连环蛋白(β-catenin)信号通路与上皮间质转化(EMT)途径相互作用介导肾癌舒尼替尼耐药的作用机制.方法 用逐步递增药物浓度法构建舒尼替尼耐药肾癌细胞株,并分为耐药组、lv-NC组和lv-Twist组,另选取人肾癌细胞株作为正常组.正常组和耐药组均给予常规细胞培养;lv-NC组给予含2.25 × 108 TU·mL-1 lv-NC慢病毒悬液40μL处置72 h;lv-Twist组给予含 1.64 × 108 TU·mL-1 lv-Twist 慢病毒悬液 50 μL 处置72 h.用流式细胞仪检测细胞凋亡能力,用细胞划痕实验检测细胞迁移能力,用Transwell实验检测细胞侵袭能力,用蛋白质印迹法检测Wnt1、β-连环蛋白和扭转蛋白(Twist)的表达水平.结果 正常组、耐药组、lv-NC组和lv-Twist组的细胞凋亡率分别为(17.60±0.59)%、(8.61±0.34)%、(8.60±0.40)%和(3.10±0.34)%,迁移率分别为(14.10±0.12)%、(27.64±0.41)%、(14.24±0.45)%和(32.74±2.53)%,侵袭细胞数目分别为(27.33±1.15)、(53.33±1.53)、(46.00±2.65)和(99.33±2.52)个,Wnt1 蛋白相对表达水平分别为 0.10±0.01、0.96±0.06、0.39±0.03 和 3.09±0.31,β-catenin 蛋白相对表达水平分别为 0.39±0.01、1.48±0.16、0.81±0.05 和 1.24±0.14,Twist 蛋白相对表达水平分别为 0.10±0.02、0.91±0.04、0.39±0.03 和 3.09±0.31.耐药组的上述指标与正常组相比,lv-Twist组的上述指标与lv-NC组相比,在统计学上差异均有统计学意义(均P<0.05).结论 EMT相关蛋白Twist通过与Wnt/β-catenin信号通路相互作用介导肾癌舒尼替尼耐药.
Research of the interaction between Wnt/β-catenin signaling and the EMT pathway in mediating sunitinib-resistance in renal cancer cells
Objective To investigate the mechanism of the interaction between Wnt/β-catenin signaling and the epithelial mesenchymal transition(EMT)pathway in mediating sunitinib-resistance in renal cancer cells.Methods The sunitinib-resistant kidney cancer cell lines were constructed by stepwise increase in drug concentrations method with sunitinib,and were divided into resistance group,lv-NC group and lv-Twist group,and human kidney cancer cell lines were selected as normal group.The normal and drug-resistant groups were treated with conventional culture;the lv-NC group was treated with 40 μL of lv-NC lentivirus supernatant containing 2.25 × 108 TU·mL-1 for 72 h,and the lv-Twist group was treated with 50 μL of Twist lentivirus supernatant containing 1.64 × 108 TU·mL-1 for 72 h.The apoptosis ability was detected by flow cytometry;the cell migration ability was detected by cell scratch assay;the cell invasion ability was detected by Transwell assay;and the protein expression levels of Wnt1,β-catenin and Twist were detected by Western blotting assay.Results The apoptosis rates of control,resistant,lv-NC and lv-Twist groups were(17.60±0.59)%,(8.61±0.34)%,(8.60±0.40)%and(3.10±0.34)%;the migration rates were(14.10±0.12)%,(27.64±0.41)%,(14.24±0.45)%and(32.74±2.53)%;the number of invading cells was 27.33±1.15,53.33±1.53,46.00±2.65 and 99.33±2.52;the relative expression levels of Wnt1 protein were 0.10±0.01,0.96±0.06,0.39±0.03 and 3.09±0.31;the relative expression levels of β-catenin protein were 0.39±0.01,1.48±0.16,0.81±0.05 and 1.24±0.14;the relative expression levels of Twist protein were 0.10±0.02,0.91±0.04,0.39±0.03 and 3.09±0.31,respectively.The differences of above indexes were statistically significant between the resistant group and the normal group,and between the lv-Twist group and the lv-NC group(all P<0.05).Conclusion Twist(EMT related protein)mediates sunitinib resistance in renal cell carcinoma by interacting with Wnt/β-catenin signaling pathway.

sunitinibWnt/β-cateninepithelial mesenchymal transitiondrug resistancerenal carcinoma

蔡芳震、张燕美、黄思淮、刘文彬、卓伟峰、李建伟

展开 >

福建医科大学附属第二医院泌尿外科,福建泉州 362000

晋江市医院泌尿外科,福建泉州 362200

舒尼替尼 Wnt/β-连环蛋白 上皮间质转化 耐药 肾癌

福建省自然科学基金资助项目福建省自然科学基金资助项目

2020J012042020J01206

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(17)